REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 DIANA LOCKWOOD, London School of Hygiene and Tropical Medicine
ICAAC delegates heard that ‘hidden’ leprosy can be triggered in some patients who are receiving HIV antiretroviral therapy. So what might this mean for the countries that are rolling out this therapy to large numbers of people? Derek Thorne discussed the issue with Diana Lockwood of the London School of Hygiene and Tropical Medicine.
PAUL WEIDLE, Centers for Disease Control and Prevention, Atlanta
REFERENCE: Lancet 2006; 368:1587-94
In rural sub-Saharan Africa there are many barriers to
[...] Audio Journal of Medicine Starting Antiretroviral <b>Therapy</b> Can <b>…<… [...]
[...] Audio Journal of Medicine Starting Antiretroviral <b>Therapy</b> Can <b>…<… [...]